Zydus Lifesciences informs about press release

19 Dec 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated December 19, 2024, titled ‘Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

911.95 10.65 (1.18%)
31-Dec-2025 10:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.70
Dr. Reddys Lab 1263.70
Cipla 1498.55
Zydus Lifesciences 911.95
Lupin 2090.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×